Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02402348 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
A Early Phase 1 study, sponsored by West Virginia University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02402348 is a Early Phase 1 study that was terminated before completion, run by West Virginia University. The registered enrollment target is 3 participants.
The verdict
NCT02402348, a Early Phase 1 study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The study researchers want to look at the overall effects that Metformin may have on the tumor characteristics of Head and Neck cancer cells as well as the interactions that Metformin has on the growth or death of tumor cells.
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02402348
The ClinicalTrials.gov registry entry for NCT02402348 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT02402348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02402348 about?
NCT02402348 is a clinical study titled "Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis". The study researchers want to look at the overall effects that Metformin may have on the tumor characteristics of Head and Neck cancer cells as well as the interactions that Metformin has on the growth or death of tumor cells.
What is the current status of trial NCT02402348?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2014-12. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02402348?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT02402348?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.